Published in J Physiol (Paris) on January 01, 1979
The concept of selectivity in 5-HT receptor research. Eur J Pharmacol (1990) 1.32
Pimozide, a chemically novel, highly potent and orally long-acting neuroleptic drug. 3. Regional distribution of pimozide and of haloperidol in the dog brain. Arzneimittelforschung (1968) 1.11
Pharmacokinetic-pharmacodynamic relationship of the cardiovascular effects of adenosine A1 receptor agonist N6-cyclopentyladenosine in the rat. J Pharmacol Exp Ther (1994) 1.04
Characterization of ecto-ATPase on human blood cells. A physiological role in platelet aggregation? Biochem Pharmacol (1993) 1.01
Conjunctival keratinisation, an abnormal reaction to an ocular beta-blocker. Acta Ophthalmol (Copenh) (1989) 0.98
Serotonin, dopamine and norepinephrine transporters in the central nervous system and their inhibitors. Prog Drug Res (2000) 0.97
1H-imidazo[4,5-c]quinolin-4-amines: novel non-xanthine adenosine antagonists. J Med Chem (1991) 0.96
A steric and electrostatic comparison of three models for the agonist/antagonist binding site on the adenosine A1 receptor. J Med Chem (1992) 0.93
Suramin analogs, divalent cations and ATP gamma S as inhibitors of ecto-ATPase. Naunyn Schmiedebergs Arch Pharmacol (1995) 0.93
A model for the antagonist binding site on the adenosine A1 receptor, based on steric, electrostatic, and hydrophobic properties. J Med Chem (1990) 0.91
Dexetimide, a useful tool in acetylcholine-receptor localization. Eur J Pharmacol (1973) 0.89
Pharmacokinetic modelling of the haemodynamic effects of the A2a adenosine receptor agonist CGS 21680C in conscious normotensive rats. Br J Pharmacol (1995) 0.88
The 5-HT1A receptor and its ligands: structure and function. Prog Drug Res (1999) 0.87
Adenosine derivatives with N6-alkyl, -alkylamine or -alkyladenosine substituents as probes for the A1-receptor. FEBS Lett (1987) 0.87
Ribose-modified adenosine analogues as potential partial agonists for the adenosine receptor. J Med Chem (1995) 0.86
High-performance liquid chromatography of the adenosine A1 agonist N6-cyclopentyladenosine and the A1 antagonist 8-cyclopentyltheophylline and its application in a pharmacokinetic study in rats. J Chromatogr (1993) 0.86
5-HT(3) receptor antagonists and anxiety; a preclinical and clinical review. Eur Neuropsychopharmacol (2000) 0.85
Mapping the N6-region of the adenosine A1 receptor with computer graphics. Eur J Pharmacol (1989) 0.85
Relative binding orientations of adenosine A1 receptor ligands--a test case for Distributed Multipole Analysis in medicinal chemistry. J Comput Aided Mol Des (1995) 0.84
Chemical modification of adenosine A1 receptors. Implications for the interaction with R-PIA, DPCPX and amiloride. Biochem Pharmacol (1990) 0.84
The absolute configuration and crystal structure of the anticholinergic drug dexbenzetimide. Nature (1971) 0.84
Receptor binding profiles of amiloride analogues provide no evidence for a link between receptors and the Na+/H+ exchanger, but indicate a common structure on receptor proteins. J Recept Res (1991) 0.83
Quantification of the in vivo potency of the adenosine A2 receptor antagonist 8-(3-chlorostyryl)caffeine. J Pharmacol Exp Ther (1995) 0.82
Binding of the radioligand [35S]adenosine 5'-O-(2-thiodiphosphate) and intracellular calcium response in rat liver parenchymal cells. Biochem Pharmacol (1993) 0.82
Interaction of amiloride and its analogues with adenosine A1 receptors in calf brain. Biochem Pharmacol (1990) 0.82
Deoxyribose analogues of N6-cyclopentyladenosine (CPA): partial agonists at the adenosine A1 receptor in vivo. Br J Pharmacol (1995) 0.81
Novel competitive antagonists for P2 purinoceptors. Eur J Pharmacol (1994) 0.81
Relationships between structure and alpha-adrenergic receptor affinity of clonidine and some related cyclic amidines. Eur J Pharmacol (1981) 0.81
Pharmacokinetic-pharmacodynamic modelling of the cardiovascular effects of R- and S-N6-phenylisopropyladenosine in conscious normotensive rats. J Pharmacol Exp Ther (1995) 0.80
Distribution, excretion and metabolism of neuroleptics of the butyrophenone type. I. Excretion and metabolism of haloperidol and nine related butyrophenone-derivatives in the Wistar rat. Eur J Pharmacol (1967) 0.80
Pharmacokinetic-haemodynamic relationships of 2-chloroadenosine at adenosine A1 and A2a receptors in vivo. Br J Pharmacol (1996) 0.79
Mapping the xanthine C8-region of the adenosine A1 receptor with computer graphics. Eur J Pharmacol (1991) 0.79
The antiarrhythmic properties of beta-adrenoceptor antagonists. Trends Pharmacol Sci (1989) 0.79
The metabolism and excretion of cinnarizine by rats. Life Sci (1968) 0.78
The mode of interaction of amiloride and some of its analogues with the adenosine A1 receptor. Neurochem Int (1992) 0.78
Nucleoside transport inhibition and platelet aggregation in human blood: R75231 and its enantiomers, draflazine and R88016. Eur J Pharmacol (1994) 0.78
Structure-affinity relationship studies on 5-HT1A receptor ligands. 2. Heterobicyclic phenylpiperazines with N4-aralkyl substituents. J Med Chem (1994) 0.77
Purification and characterization of enkephalin-degradating enzymes from calf-brain striatum. Biochem Biophys Res Commun (1983) 0.77
Localization of ( 3 H)pimozide in the rat brain in relation to its anti-amphetamine potency. J Pharm Pharmacol (1972) 0.77
Halopemide, a new psychotropic agent. Cerebral distribution and receptor interactions. Pharm Weekbl Sci (1985) 0.76
Effects of halopemide on GABA receptor binding, uptake and release. Brain Res (1981) 0.76
Hybrid cholecystokinin-A antagonists based on molecular modeling of lorglumide and L-364,718. J Med Chem (1992) 0.76
Opiate receptor interaction of compounds derived from or structurally related to fentanyl. J Med Chem (1981) 0.75
Regional localization of halopemide, a new psychotropic agent, in the rat brain. Eur J Pharmacol (1978) 0.75
Research in the Division of Medicinal Chemistry. Pharm Weekbl Sci (1985) 0.75
Effect of various enkephalin analogs and dipeptides on the enzymatic activity of enkephalinase B isolated from calf-brain striatum. Life Sci (1986) 0.75
Distribution excretion and metabolism of neuroleptics of the butyrophenone type. II. Distribution, excretion and metabolism of haloperidol in Sprague-Dawley rats. Eur J Pharmacol (1967) 0.75
Functional characteristics of a series of N4-substituted 1-(2,3-dihydro-1,4-benzodioxin-5-yl)piperazines as 5-HT1A receptor ligands. Structure-activity relationships. Bioorg Med Chem Lett (1998) 0.75
The combined use of high-performance liquid chromatography and radioimmunoassay for the bioanalysis of nicomorphine and its metabolites. J Pharm Biomed Anal (1984) 0.75
Synthesis of enkephalinase B inhibitors, and their activity on isolated enkephalin-degrading enzymes. Eur J Pharmacol (1987) 0.75
Angiotensin converting enzyme inhibitors. Pharm Weekbl Sci (1982) 0.75
The metabolism and excretion of benzetimide hydrochloride (R 4929) by rats. Life Sci (1968) 0.75
The regional localisation of a new potent centrally acting antihypertensive agent R 28935 and its less active threo-isomer R29814 in the cat brain. Eur J Pharmacol (1977) 0.75
Computer modelling of the binding of non-selective ligands to biological receptors. Pharm Weekbl Sci (1983) 0.75
Halopemide and benzodiazepine binding sites. Arch Int Pharmacodyn Ther (1982) 0.75
Inhibitors of calf-brain enkephalinase A and B. Life Sci (1983) 0.75
Improved qualitative method for establishing flunitrazepam abuse using urine samples and column liquid chromatography with fluorimetric detection. J Chromatogr (1986) 0.75
Difenoxine (R15403), the active metabolite of diphenoxylate (R1132). 1. The excretion and metabolism in rats of difenoxine, the pharmacologically active metabolite of the antidiarrheal agent diphenoxylate. Arzneimittelforschung (1972) 0.75
Influence of the molecular structure of N6-(omega-aminoalkyl)adenosines on adenosine receptor affinity and intrinsic activity. Eur J Pharmacol (1989) 0.75
Opiate receptor binding of nicomorphine and its hydrolysis products in rat brain. Eur J Pharmacol (1982) 0.75
Adenosine-A1 receptors are not coupled to Ca2+ uptake in rat brain synaptosomes. Biochem Pharmacol (1989) 0.75
Partial agonism of the nonselective adenosine receptor agonist 8-butylaminoadenosine at the A1 receptor in vivo. J Pharmacol Exp Ther (1996) 0.75
A series of N4-imidoethyl derivatives of 1-(2,3-dihydro-1,4-benzodioxin-5-yl)piperazine as 5-HT1A receptor ligands: synthesis and structure-affinity relationships. J Med Chem (1995) 0.75
Molecular modelling of CCK-A receptors. Drug Des Discov (1994) 0.75
Effects of halopemide on potassium-induced release of radiolabeled neurotransmitters from rat cerebrocortical slices in vitro. Arch Int Pharmacodyn Ther (1980) 0.75
Effects of halopemide, a new psychotropic agent, on the uptake of serotonin by blood platelets. Arch Int Pharmacodyn Ther (1979) 0.75
Molecular modelling of asperlicin derived cholecystokinin A receptor antagonists. Eur J Pharmacol (1992) 0.75
Structure-affinity relationship studies on 5-HT1A receptor ligands. 1. Heterobicyclic phenylpiperazines with N4-alkyl substituents. J Med Chem (1993) 0.75
Regional distribution of halopemide, a new psychotropic agent, in the rat brain at different time intervals and after chronic administration. Life Sci (1979) 0.75
Biotransformation of neuroleptanalgesics. Int Anesthesiol Clin (1974) 0.75
The metabolism and excretion of the neuroleptic drug pimozide (R 6238) by the wistar rat. Life Sci (1969) 0.75
[3H]batrachotoxinin-A 20-alpha-benzoate binding to sodium channels in rat brain: sensitivity to tetrodotoxin and divalent cations. Eur J Pharmacol (1988) 0.75
The regional localization of R28935 in the cat brain as dependent on the route of administration. Naunyn Schmiedebergs Arch Pharmacol (1979) 0.75
Isolation and characterization of an enkephalin-hydrolyzing dipeptidyl-aminopeptidase from calf-brain striatum. Neuropeptides (1985) 0.75